Sylentis ( Grupo Zeltia ) Farmaco Glaucoma .

[RNA interferences therapeutics: a new approach to the treatment of ocular diseases.]Arch Soc Esp Oftalmol. 2007 May;82(5):261-4. Spanish. No abstract available.